Toxicity management for patients receiving novel T-cell engaging therapies.

Barrett, David M

Toxicity management for patients receiving novel T-cell engaging therapies. [electronic resource] - Current opinion in pediatrics Feb 2014 - 43-9 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

1531-698X

10.1097/MOP.0000000000000043 doi


Antibodies, Bispecific--adverse effects
Antigens, CD19--immunology
Child
Cytokines--biosynthesis
Humans
Immune System Diseases--immunology
Immunotherapy--adverse effects
Lymphocyte Activation--immunology
Lymphohistiocytosis, Hemophagocytic--immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma--immunology
Receptors, Antigen, T-Cell--immunology
Syndrome
T-Lymphocytes--immunology